false
zh-CN,zh-TW,en,fr,de,hi,ja,ko,pt,es
Catalog
Revolutionizing Type 1 Diabetes Care through Advan ...
Why, When, Who and How to Screen
Why, When, Who and How to Screen
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The lesson by Riitta Veijola from the University of Oulu covers the importance of screening for type 1 diabetes (T1D). T1D progresses through three stages, with the first two being pre-symptomatic. Autoantibody screening enables early detection, crucial for preventing complications like diabetic ketoacidosis. Screening is recommended for those at higher risk, such as individuals with a family history or carrying certain genetic markers. Programs in some countries screen children at specific ages, while adult screening occurs if in a risk group. Early detection allows patient education and participation in intervention trials, helping manage the rising incidence of T1D.
Keywords
type 1 diabetes
autoantibody screening
early detection
genetic risk factors
diabetic ketoacidosis prevention
EndoCareers
|
Contact Us
|
Privacy Policy
|
Terms of Use
CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036
202.971.3636 | 888.363.6274
×